Literature DB >> 14563759

Cochrane at crossroads over drug company sponsorship.

Ray Moynihan1.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2003        PMID： 14563759      PMCID： PMC218825          DOI： 10.1136/bmj.327.7420.924

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Authors:  Joel Lexchin; Lisa A Bero; Benjamin Djulbegovic; Otavio Clark
Journal:  BMJ       Date:  2003-05-31

Review 2.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

3.  How many Cochrane reviews are needed to cover existing evidence on the effects of health care interventions?

Authors:  Susan Mallett; Mike Clarke
Journal:  ACP J Club       Date:  2003 Jul-Aug

Review 4.  Rizatriptan for acute migraine.

Authors:  A D Oldman; L A Smith; H J McQuay; R A Moore
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 5.  Eletriptan for acute migraine.

Authors:  L A Smith; A D Oldman; H J McQuay; R A Moore
Journal:  Cochrane Database Syst Rev       Date:  2001
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.